6838
台新藥
-0.30 (-1.26%)23.6090成交張數–本益比2.60股價淨值比0.00%殖利率2026-09-11資料日期
毛利率、營業利益率、淨利率
單季;近十年
單季營收
億元
| 季度 | 營收(億) | 營收年增 | 毛利(億) | 毛利率 | 營業利益(億) | 營業利益率 | 淨利率 |
|---|---|---|---|---|---|---|---|
| 2026Q2 | 0.0 | -36.5% | -0.0 | -153.3% | -0.8 | -2501.3% | -2235.1% |
| 2026Q1 | 0.5 | 7546.8% | 0.4 | 86.9% | -0.1 | -23.4% | -33.6% |
| 2025Q4 | 0.0 | -45.3% | 0.0 | 15.8% | -0.4 | -1220.7% | -1486.8% |
| 2025Q3 | 0.0 | -79.0% | -0.1 | -570.7% | -0.4 | -4896.9% | -6497.5% |
| 2025Q2 | 0.0 | – | 0.0 | 78.9% | -0.5 | -1085.4% | 1350.5% |
| 2025Q1 | 0.0 | – | -0.0 | -112.1% | -0.3 | -5877.6% | -6859.4% |
| 2024Q4 | 0.1 | – | 0.0 | 45.1% | -0.4 | -612.4% | -655.6% |
| 2024Q3 | 0.0 | – | 0.0 | 14.7% | -0.5 | -1197.9% | -1062.7% |